Thomas A. Murray

Also affiliated with The Medical Center of Aurora, Minnesota Department of Health

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial”.

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00299-2

N/A

5.8DataRank · unranked

226 citations

John B. Buse, David Liebovitz, Jacinda M. Nicklas, Michael A. Puskarich, Ken Cohen +72 more

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Annals of Internal Medicine(2021)10.7326/m21-3507

N/A

3.8DataRank · unranked

76 citations

Jens Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L Holland, Robert L. Gottlieb +88 more

Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciae159

N/A

1.0DataRank · unranked

46 citations

Kenneth B. Beckman, Tanvi Mehta, Amy B. Karger, David J. Odde, Christopher J. Tignanelli +70 more

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial

The Lancet Oncology(2025)10.1016/s1470-2045(25)00083-x

N/A

0.923DataRank · unranked

53 citations

Modassir S Choudhry, Timothy K. Starr, Timothy D. Folsom, Jason Bell, Blaine Rathmann +28 more

Rationale and methods of the Advanced R2Eperfusion STrategies for Refractory Cardiac Arrest (ARREST) trial

American Heart Journal(2020)10.1016/j.ahj.2020.07.006

N/A

0.524DataRank · unranked

32 citations

Rajat Kalra, Marinos Kosmopoulos, Emily Walser, Jason A. Bartos, Thomas A. Murray +3 more

Outcome trajectory estimation for optimal dynamic treatment regimes with repeated measures

Journal of the Royal Statistical Society Series C (Applied Statistics)(2023)10.1093/jrsssc/qlad037

N/A

0.292DataRank · unranked

6 citations

David M. Vock, Megan E. Patrick, Lizbeth H. Finestack, Thomas A. Murray, Y. Zhang

Bayesian hierarchical models incorporating study‐level covariates for multivariate meta‐analysis of diagnostic tests without a gold standard with application to COVID‐19

Statistics in Medicine(2023)10.1002/sim.9902

N/A

0.241DataRank · unranked

4 citations

Thomas A. Murray, Mengli Xiao, Lifeng Lin, Demissie Alemayehu, Haitao Chu +1 more

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad446

N/A

0.241DataRank · unranked

4 citations

Greg Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw‐Saliba +93 more

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

Journal of Clinical and Translational Science(2023)10.1017/cts.2023.668

N/A

0.208DataRank · unranked

3 citations

Dustin Kakach, Christopher J. Tignanelli, David Liebovitz, Jacinda M. Nicklas, Ken Cohen +16 more

Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Clinical Microbiology and Infection(2025)10.1016/j.cmi.2025.02.002

N/A

0.204DataRank · unranked

2 citations

Gregory Grandits, Lianne Siegel, Nicole Engen, Christina E. Barkauskas, Nnakelu Eriobu +25 more

Design considerations and analytical framework for reliably identifying a beneficial individualized treatment rule

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106951

N/A

0.165DataRank · unranked

2 citations

Thomas A. Murray, Kyle Rudser, Alexander J. Rothman, Anne C. Melzer, Anne M. Joseph +2 more

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf282

N/A

0DataRank · unranked

4 citations

Eric Chun‐Pu Chu, Thomas A. Murray, Carolyn T. Bramante, Carlee Moser, Naomi Givens +17 more

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf443

N/A

0DataRank · unranked

0 citations

Eric Chun‐Pu Chu, Thomas A. Murray, Carolyn T. Bramante, Carlee Moser, Naomi Givens +17 more

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Critical Care(2020)10.1186/s13054-020-02894-7

N/A

0DataRank · unranked

12 citations

David R. Boulware, Matthew A. Sparks, Timothy W. Schacker, Bradley Benson, Jeffrey A. Sparks +6 more

Protocol for a randomized controlled trial of a resistance exercise training to treat major depression via cerebrovascular mechanisms (RESIST Trial)

Trials(2025)10.1186/s13063-025-09025-z

N/A

0DataRank · unranked

0 citations

Seana L. Smith, John M. Gidley, A. Camacho Molina, Sydney L. Churchill, Shania J.E. Kelly +10 more

Robust Adaptive Incorporation of Historical Control Data in a Randomized Trial of External Cooling to Treat Septic Shock

Bayesian Analysis(2020)10.1214/20-ba1229

N/A

0DataRank · unranked

6 citations

Peter F. Thall, Frédérique Schortgen, Pierre Asfar, Sarah Zohar, Sandrine Katsahian +1 more

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

Clinical Trials(2021)10.1177/17407745211049829

N/A

0DataRank · unranked

34 citations

Abdel G. Babiker, Jason V. Baker, Christina E. Barkauskas, Samuel M. Brown, Christina C. Chang +23 more

Effect of losartan on hospitalized patients with COVID-19-induced lung injury: A randomized clinical trial

medRxiv(2021)10.1101/2021.08.25.21262623

N/A

0DataRank · unranked

5 citations

Nicholas E. Ingraham, Lisa H. Merck, Brian E. Driver, David A. Wacker, Lauren Page Black +29 more

Bayesian variable selection in hierarchical difference-in-differences models

Statistical Methods in Medical Research(2021)10.1177/09622802211051087

N/A

0DataRank · unranked

0 citations

Eric F. Lock, Thomas A. Murray, Caroline Carlin, James Normington

Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac066

N/A

0DataRank · unranked

26 citations

Jennifer Proper, David R. Boulware, Amy B. Karger, Thomas A. Murray, V. D. P. Rao +23 more

Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

medRxiv(2022)10.1101/2022.12.21.22283753

N/A

0DataRank · unranked

37 citations

John B. Buse, David Liebovitz, Jacinda M. Nicklas, Michael A. Puskarich, Ken Cohen +25 more

Modified interactive Q-learning for attenuating the impact of model misspecification with treatment effect heterogeneity

Aranzadi social(2023)10.1177/09622802231206471

N/A

0DataRank · unranked

0 citations

David M. Vock, Megan E. Patrick, Thomas A. Murray, Y. Zhang

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciad780

N/A

0DataRank · unranked

16 citations

Jacquie Nordwall, Dominique L. Braun, Lucy Chung, Jordan Coslet, Tatyana Der +93 more

Phase I/II Design for Selecting Subgroup‐Specific Optimal Biological Doses for Prespecified Subgroups

Statistics in Medicine(2024)10.1002/sim.10256

N/A

0DataRank · unranked

3 citations

Thomas A. Murray, Anne Eaton, Scott P. Porter

Optimal timing for an accelerated interim futility analysis incorporating real world data

Contemporary Clinical Trials(2024)10.1016/j.cct.2024.107489

N/A

0DataRank · unranked

1 citations

Thomas A. Murray, Joseph S. Koopmeiners, Lillian Haine

Restricted Win Probability with Bayesian Estimation for Implementing the Estimand Framework in Clinical Trials With a Time-to-Event Outcome

arXiv (Cornell University)(2024)10.48550/arxiv.2411.02755

N/A

0DataRank · unranked

0 citations

Xianghua Luo, Thomas A. Murray, Michelle Leeberg